Picture of Beroni logo

BTG Beroni Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareMicro Cap

Momentum

Relative Strength (%)
1m-75.01%
3m-74.77%
6m-74.38%
1yr-74.76%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MA-81.4%
200d MA-76.42%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-15.79%
Return on Equity-16.69%
Operating Margin-133.08%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 201931st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2019 / 2020

Blurred out image of Beroni EPS forecast chart

Profile Summary

Beroni Group Limited is an Australia-based international biopharmaceutical company. The Company is principally engaged in sales of smoking control product (NicoBloc), air purifiers, water filters, healthcare products and supplements, cell therapies, cosmetics and viral diagnostic kits. The Company is also engaged in investing in the research and development of oncology drugs and therapies. The Company’s diversified portfolio is comprised of virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. The Company has operations in Australia, the United States, China and Japan. Its products offering include NicoBloc, CII-ArboViroPlex rRT-PCR assay and stem cell cosmetic products, including AGG Skin-Smoothing and Anti-Wrinkle Facial Mask, ODd Skin Repair Essence, ODd Beroni Beauty Facial Mask, AGG Skin-Smoothing and Anti-Wrinkle Essence and other.

Directors

    Last Annual
    December 31st, 2018
    Last Interim
    December 31st, 2018
    Incorporated
    June 17th, 2016
    Public Since
    May 12th, 2017
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    au flag iconNational Stock Exchange of Australia
    Shares in Issue
    17,525,587

    BTG Share Price Performance

    FAQ